Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiyi Yu

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Annals of Surgery|October 15, 2015
Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon CancerWenju Chang, Ye Wei, Li Ren, et al.
Lancet (London, England)|November 15, 2025
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in ChinaJie Gao, Mengtao Li, Ming Sun, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2021
Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancersChuanhua Zhao, Lihong Wu, Dandan Liang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2025
Lactylation-Driven NUPR1 Promotes Immunosuppression of Tumor-Infiltrating Macrophages in Hepatocellular CarcinomaJialiang Cai, Peiling Zhang, Yufan Cai, et al.
Journal of Cellular Physiology|February 13, 2020
A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancerKe Peng, Erbao Chen, Wei Li, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 12, 2018
An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer PatientsLi Liang, Jiawen Tian, Yiyi Yu, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Nivolumab-associated DRESS in a genetic susceptible individualLuoyan Ai, Jie Gao, Shihai Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastasesLe-Chi Ye, Tian-Shu Liu, Li Ren, et al.
Innovation (Cambridge (Mass.))|May 26, 2022
Toripalimab in advanced biliary tract cancerWei Li, Yueqi Wang, Yiyi Yu, et al.
Translational Gastroenterology and Hepatology|February 6, 2024
Clinical significance of peripheral T-cell receptor repertoire profiling and individualized nomograms in patients with gastrointestinal cancer treated with anti-programmed death 1 antibodyJing Wu, Yiyi Yu, Shilong Zhang, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Annals of Surgery|October 15, 2015
Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon CancerWenju Chang, Ye Wei, Li Ren, et al.
Lancet (London, England)|November 15, 2025
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in ChinaJie Gao, Mengtao Li, Ming Sun, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2021
Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancersChuanhua Zhao, Lihong Wu, Dandan Liang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2025
Lactylation-Driven NUPR1 Promotes Immunosuppression of Tumor-Infiltrating Macrophages in Hepatocellular CarcinomaJialiang Cai, Peiling Zhang, Yufan Cai, et al.
Journal of Cellular Physiology|February 13, 2020
A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancerKe Peng, Erbao Chen, Wei Li, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 12, 2018
An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer PatientsLi Liang, Jiawen Tian, Yiyi Yu, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Nivolumab-associated DRESS in a genetic susceptible individualLuoyan Ai, Jie Gao, Shihai Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastasesLe-Chi Ye, Tian-Shu Liu, Li Ren, et al.
Innovation (Cambridge (Mass.))|May 26, 2022
Toripalimab in advanced biliary tract cancerWei Li, Yueqi Wang, Yiyi Yu, et al.
Translational Gastroenterology and Hepatology|February 6, 2024
Clinical significance of peripheral T-cell receptor repertoire profiling and individualized nomograms in patients with gastrointestinal cancer treated with anti-programmed death 1 antibodyJing Wu, Yiyi Yu, Shilong Zhang, et al.
Pageof 13